Literature DB >> 7979341

Palatability of a meal influences release of beta-endorphin, and of potential regulators of food intake in healthy human subjects.

J C Melchior1, D Rigaud, J A Chayvialle, N Colas-Linhart, M D Laforest, A Petiet, E Comoy, M Apfelbaum.   

Abstract

The effect of the palatability of a meal was tested on the post-prandial release of several gut hormones or neuropeptides which are known to have an effect on intake and satiety. Hormonal response was determined in plasma during the 3 h after a highly palatable and energy-rich meal or after the same meal served cold in a poorly acceptable form, as well as while fasting. The early post-prandial pancreatic polypeptide and neurotensin response was significantly higher after the highly palatable meal than after the cold one. Later responses differed only for pancreatic polypeptide. No difference was observed in cholecystokinin and neuropeptide Y levels. Post-prandial levels of beta-endorphin were elevated only after the cold meal and were associated with an elevated response of ACTH. We suggest that beta-endorphin might be secreted in response to an aversion towards the non-palatable cold meal. This could, subsequently, inhibit the cephalic phase of pancreatic polypeptide response and the early post-prandial response of neurotensin by a central anticholinergic effect. This study evidences an effect of palatability on the modulation of the digestive hormonal response after a meal.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7979341     DOI: 10.1006/appe.1994.1022

Source DB:  PubMed          Journal:  Appetite        ISSN: 0195-6663            Impact factor:   3.868


  2 in total

1.  A randomized, double-blind, placebo-controlled pilot study of naltrexone to counteract antipsychotic-associated weight gain: proof of concept.

Authors:  Cenk Tek; Joseph Ratliff; Erin Reutenauer; Rohan Ganguli; Stephanie S O'Malley
Journal:  J Clin Psychopharmacol       Date:  2014-10       Impact factor: 3.153

2.  Investigating the safety and efficacy of naltrexone for anti-psychotic induced weight gain in severe mental illness: study protocol of a double-blind, randomized, placebo-controlled trial.

Authors:  Cenk Tek; Sinan Guloksuz; Vinod H Srihari; Erin L Reutenauer
Journal:  BMC Psychiatry       Date:  2013-06-27       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.